Mumps Vaccine (MumpsVax) Market Forecast and Analysis: Key Insights into Growth, Trends, and Emerging Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the Growth Rate of the Mumps Vaccine (MumpsVax) Market Shape Industry Trends by 2034?
The market for the mumps vaccine (mumpsvax) has witnessed robust growth in the past few years. It is projected to expand from a value of $2,057.93 million in 2024 to $2,210.59 million in 2025, reflecting a compound annual growth rate (CAGR) of 7.4%. Various factors have driven the growth during the historic period, including the rise in pediatric vaccination rates, proliferation of global health initiatives, growing public confidence in vaccines, heightened travel awareness and expanded immunization campaigns.
In the upcoming years, a significant surge is expected in the mumps vaccine (mumpsvax) market, projecting to escalate to $2,902.21 million by 2029, with a compound annual growth rate (CAGR) of 7.0%. The speculated growth during the forecast period can be ascribed to the escalating occurrence of diseases that can be prevented by vaccines, increased awareness regarding adult vaccinations, heightened health consciousness, expansion of immunization programs, and the rise of global health initiatives. Key trends for the forecast period encompass customized vaccination approaches, incorporation of digital health, improved surveillance systems, research and development in adult vaccination, and the integration of artificial intelligence.
Which Primary Drivers Are Supporting the Continued Expansion of the Mumps Vaccine (MumpsVax) Market?
The rise in contagious illnesses is set to catalyze the growth of the MumpsVax market. These diseases manifest due to harmful microbes, such as fungi, bacteria, viruses, or parasites, which can be spread from person to person or from contact with polluted environments. The surge in such diseases is largely fueled by factors like globalisation, climate change, urbanisation, and shifts in human demographics and behavior, which facilitate the spread and emergence of pathogens. MumpsVax, a vaccine for mumps, is primarily utilized to prevent an infection caused by the mumps virus, usually included in the MMR (measles, mumps, rubella) vaccine. For example, in August 2024, a report from the UK Health Security Agency indicated that, in 2023, West Midlands region registered the highest number of measles incidents, with 160 cases (44%), followed by London’s 122 cases (33%). Noteworthy is that 63% of the entire cases, equalling to 232 cases, were children under 10. Measles surged dramatically towards the year’s close, with 157 fresh cases documented in December, in contrast to only 45 in November. Therefore, the increasing prevalence of contagious diseases is fueling the MumpsVax market.
Explore Comprehensive Insights Into The Global Mumps Vaccine (MumpsVax) Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19909&type=smp
Who Are the Key Market Players Influencing the Growth of the Mumps Vaccine (MumpsVax) Industry?
Major companies operating in the mumps vaccine (mumpsvax) market include Merck & Co. Inc., GlaxoSmithKline plc
Secure Your Global Mumps Vaccine (MumpsVax) Market Report Now for Fast and Efficient Delivery!
https://www.thebusinessresearchcompany.com/report/mumps-vaccine-mumpsvax-global-market-report
What Are the Main Segments of the Mumps Vaccine (MumpsVax) Market, and How Are They Evolving?
The mumps vaccine (mumpsvax)market covered in this report is segmented –
1) By Product Type: Monovalent; Combinational; Divalent; Trivalent; Other Product Types
2) By Age Group: Pediatric; Adult
3) By Distribution Channels: Hospital pharmacies; Drug Stores; Retail Pharmacies
4) By End-User: Pediatric Clinic; Hospitals; Non-Governmental Organization (NGOs); Other End-Users
Which Regions Are Emerging as Leaders in the Mumps Vaccine (MumpsVax) Market?
North America was the largest region in the mumps vaccine (mumpsvax) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mumps vaccine (mumpsvax) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Defining Features of the Mumps Vaccine (MumpsVax) Market?
Mumps vaccine (MumpsVax) is a live attenuated vaccine that prevents mumps using the Jeryl Lynn strain of the virus. Administered in two doses, it is often combined with the MMR (measles, mumps, rubella) vaccine and provides over 95% protection against mumps. Although standalone production has ceased, mumps vaccine (mumpsvax) remains crucial for public health efforts to reduce mumps outbreaks and has significantly lowered incidence rates in vaccinated populations.
Browse Through More Similar Reports By The Business Research Company:
Dendritic Cell Cancer Vaccine Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dendritic-cell-cancer-vaccine-global-market-report
Porcine Epidemic Diarrhea Vaccines Global Market Report 2025
Global Biosimilar Hormones Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
